Abstract:Coenzyme Q 0 (CoQ 0 ) obtained from Antrodia camphorata has therapeutic benefits in cancer treatment. Our previous findings in vivo and in vitro have shown that CoQ 0 affects triple-negative breast cancer cells (TNBCs) by blocking EMT and metastasis. The current study investigated the cancer-preventive activities of CoQ 0 on TNBC MDA-MB-468 and 231 cells by activating apoptotic and autophagic cell death. The CoQ 0 treatment reduced colony development and proliferation in TNBC cells. In addition, CoQ 0 triggered death activation by caspase-3 stimulation, PARP cleavage, and significantly affected Bax/Bcl-2 regulation. Autophagy was triggered by CoQ 0 , as shown by LC3-II accumulation, p62/SQSTM1 expression, ATG5 expression, ATG4B inhibition, AVO formation, and impeded Beclin-1/Bcl-2 regulation. In addition, transmission electron microscopy data showed that CoQ 0 increased autophagosome formation. The antioxidant N -acetylcysteine substantially suppressed CoQ 0 -mediated ROS generation and attenuated apoptotic- and autophagic-cell death by CoQ 0 in TNBC cells. CoQ 0 is a potential anticancer agent in treating human triple-negative breast cancers.

The anti-tumor activities of coenzyme Q0 through ROS-mediated autophagic cell death in human triple-negative breast cells